Back to Search
JOANNA BRELL, MD
MD
Hematology & Oncology Physician
NPI: 1740205350Individual
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35-066467(OH)
Research & Publications (8)
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma.
PMID 18670776·Cancer Chemother Pharmacol·2009
3-trial
Phase II study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancer.
PMID 19258727·Oncology·2009
3-trial
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.
PMID 18414865·Cancer Chemother Pharmacol·2009
3-trial
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
PMID 19399502·Cancer Chemother Pharmacol·2009
3-trial
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors.
PMID 19011760·Invest New Drugs·2009
3-trial
A rare case of melanoma recurring as subcutaneous metastatic melanoma with overlying ecchymoses.
PMID 18427064·Arch Dermatol·2008
5-case
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles.
PMID 18470481·Invest New Drugs·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 2500 METROHEALTH DR
CLEVELAND, OH 44109 - Phone
- (216) 778-5790
Quick Facts
- NPI
- 1740205350
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile